These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14697223)

  • 1. Evaluation of penicillin-based inhibitors of the class A and B beta-lactamases from Bacillus anthracis.
    Beharry Z; Chen H; Gadhachanda VR; Buynak JD; Palzkill T
    Biochem Biophys Res Commun; 2004 Jan; 313(3):541-5. PubMed ID: 14697223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-lactamase genes of the penicillin-susceptible Bacillus anthracis Sterne strain.
    Chen Y; Succi J; Tenover FC; Koehler TM
    J Bacteriol; 2003 Feb; 185(3):823-30. PubMed ID: 12533457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases.
    Bonomo RA; Rudin SA; Shlaes DM
    FEMS Microbiol Lett; 1997 Mar; 148(1):59-62. PubMed ID: 9066111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of SER-130.
    Helfand MS; Bethel CR; Hujer AM; Hujer KM; Anderson VE; Bonomo RA
    J Biol Chem; 2003 Dec; 278(52):52724-9. PubMed ID: 14534312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An extracytoplasmic function sigma factor controls beta-lactamase gene expression in Bacillus anthracis and other Bacillus cereus group species.
    Ross CL; Thomason KS; Koehler TM
    J Bacteriol; 2009 Nov; 191(21):6683-93. PubMed ID: 19717606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical characterization of beta-lactamases Bla1 and Bla2 from Bacillus anthracis.
    Materon IC; Queenan AM; Koehler TM; Bush K; Palzkill T
    Antimicrob Agents Chemother; 2003 Jun; 47(6):2040-2. PubMed ID: 12760895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An insight into the complete biophysical and biochemical characterization of novel class A beta-lactamase (Bla1) from Bacillus anthracis.
    Bhattacharya S; Junghare V; Pandey NK; Ghosh D; Patra H; Hazra S
    Int J Biol Macromol; 2020 Feb; 145():510-526. PubMed ID: 31874266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification development and characterization of the zinc-dependent metallo-β-lactamase from Bacillus anthracis.
    Schlesinger SR; Kim SG; Lee JS; Kim SK
    Biotechnol Lett; 2011 Jul; 33(7):1417-22. PubMed ID: 21369909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.
    Giakkoupi P; Tzelepi E; Legakis NJ; Tzouvelekis LS
    J Antimicrob Chemother; 1999 Jan; 43(1):23-9. PubMed ID: 10381097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of an inhibitor-resistant variant of the OHIO-1 beta-lactamase, an SHV-family class A enzyme.
    Lin S; Thomas M; Shlaes DM; Rudin SD; Knox JR; Anderson V; Bonomo RA
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):395-400. PubMed ID: 9735103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumannii.
    Vázquez-Ucha JC; Maneiro M; Martínez-Guitián M; Buynak J; Bethel CR; Bonomo RA; Bou G; Poza M; González-Bello C; Beceiro A
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penicillins and beta-lactamase inhibitor combinations.
    Mealey KL
    J Am Vet Med Assoc; 2001 Jun; 218(12):1893-6. PubMed ID: 11417732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic characterization of a slow-binding inhibitor of Bla2: thiomaltol.
    Schlesinger SR; Bruner B; Farmer PJ; Kim SK
    J Enzyme Inhib Med Chem; 2013 Feb; 28(1):137-42. PubMed ID: 22233540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
    Piddock LJ; Jin YF; Turner HL
    J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 {beta}-lactamase.
    Padayatti PS; Helfand MS; Totir MA; Carey MP; Carey PR; Bonomo RA; van den Akker F
    J Biol Chem; 2005 Oct; 280(41):34900-7. PubMed ID: 16055923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A piperacillin-tazobactam resistant Escherichia coli strain isolated from a faecal sample of a healthy volunteer.
    London N; Thomson CJ; Amyes SG; Stobberingh E
    FEMS Immunol Med Microbiol; 1995 Apr; 11(2):107-11. PubMed ID: 7640670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of AVE1330A, an innovative broad-spectrum non-beta-lactam beta-lactamase inhibitor.
    Bonnefoy A; Dupuis-Hamelin C; Steier V; Delachaume C; Seys C; Stachyra T; Fairley M; Guitton M; Lampilas M
    J Antimicrob Chemother; 2004 Aug; 54(2):410-7. PubMed ID: 15254025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penicillin sulfone inhibitors of class D beta-lactamases.
    Drawz SM; Bethel CR; Doppalapudi VR; Sheri A; Pagadala SR; Hujer AM; Skalweit MJ; Anderson VE; Chen SG; Buynak JD; Bonomo RA
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1414-24. PubMed ID: 20086146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the molecular interactions of inhibitors against Bla1 beta-lactamase towards unraveling the mechanism of antimicrobial resistance.
    Bhattacharya S; Padhi AK; Junghare V; Das N; Ghosh D; Roy P; Zhang KYJ; Hazra S
    Int J Biol Macromol; 2021 Apr; 177():337-350. PubMed ID: 33582216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Hydroxamic Acid Compounds for Inhibition of Metallo-β-Lactamase from
    Huckleby AE; Saul JG; Shin H; Desmarais S; Bokka A; Jeon J; Kim SK
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.